Xiaoqiang Li
Shanghai University(CN)Shanghai University of Engineering Science(CN)Northwestern Polytechnical University(CN)Chinese Center For Disease Control and Prevention(CN)Changchun Normal University(CN)Sichuan University(CN)West China Hospital of Sichuan University(CN)Jiangsu Provincial Center for Disease Control and Prevention(CN)Peking University Shenzhen Hospital(CN)Beaumont Hospital, Royal Oak(US)Beaumont Hospital, Troy(US)South China University of Technology(CN)
Publications by Year
Research Areas
Lung Cancer Diagnosis and Treatment, Gastric Cancer Management and Outcomes, Radiation Therapy and Dosimetry, Advanced Radiotherapy Techniques, Ferroptosis and cancer prognosis
Most-Cited Works
- → Programmed cell death‐1 (PD‐1) checkpoint blockade in combination with a mammalian target of rapamycin inhibitor restrains hepatocellular carcinoma growth induced by hepatoma cell–intrinsic PD‐1(2017)199 cited
- → MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1(2019)186 cited
- → Spot-Scanning Proton Arc (SPArc) Therapy: The First Robust and Delivery-Efficient Spot-Scanning Proton Arc Therapy(2016)155 cited
- → Management of Catheter-Related Bladder Discomfort in Patients Who Underwent Elective Surgery(2014)150 cited
- → Immunomodulatory Factor TIM3 of Cytolytic Active Genes Affected the Survival and Prognosis of Lung Adenocarcinoma Patients by Multi-Omics Analysis(2022)103 cited
- → Selective poly adenylation predicts the efficacy of immunotherapy in patients with lung adenocarcinoma by multiple omics research(2022)